%0 Journal Article %1 Olle2013Medicines %A Olle, Bernat %D 2013 %I Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. %J Nat Biotech %K gut-microbiome therapeutic-strategies %N 4 %P 309--315 %R 10.1038/nbt.2548 %T Medicines from microbiota %U http://dx.doi.org/10.1038/nbt.2548 %V 31 %X Five years after the launch of the Human Microbiome Project, several ventures are seeking to capitalize on the clinical promise of microbiome modulation. Commercialization of drugs that influence the human flora poses some unique scientific, translational and regulatory challenges.

@article{Olle2013Medicines, abstract = {Five years after the launch of the Human Microbiome Project, several ventures are seeking to capitalize on the clinical promise of microbiome modulation. Commercialization of drugs that influence the human flora poses some unique scientific, translational and regulatory challenges.}, added-at = {2018-12-02T16:09:07.000+0100}, author = {Olle, Bernat}, biburl = {https://www.bibsonomy.org/bibtex/2d84cc9e740a92283e8c02b40611dc5ac/karthikraman}, citeulike-article-id = {12247902}, citeulike-linkout-0 = {http://dx.doi.org/10.1038/nbt.2548}, citeulike-linkout-1 = {http://dx.doi.org/10.1038/nbt.2548}, day = 5, doi = {10.1038/nbt.2548}, interhash = {49015bc0416519f3f3e1e0bd1205540f}, intrahash = {d84cc9e740a92283e8c02b40611dc5ac}, issn = {1087-0156}, journal = {Nat Biotech}, keywords = {gut-microbiome therapeutic-strategies}, month = apr, number = 4, pages = {309--315}, posted-at = {2013-06-14 05:57:45}, priority = {2}, publisher = {Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.}, timestamp = {2018-12-02T16:09:07.000+0100}, title = {Medicines from microbiota}, url = {http://dx.doi.org/10.1038/nbt.2548}, volume = 31, year = 2013 }